These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8104182

  • 1. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.
    Rezaie AR, Esmon CT.
    J Biol Chem; 1993 Sep 25; 268(27):19943-8. PubMed ID: 8104182
    [Abstract] [Full Text] [Related]

  • 2. Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin.
    Le Bonniec BF, Esmon CT.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7371-5. PubMed ID: 1678522
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of residue 99 at the S2 subsite of factor Xa and activated protein C in enzyme specificity.
    Rezaie AR.
    J Biol Chem; 1996 Sep 27; 271(39):23807-14. PubMed ID: 8798609
    [Abstract] [Full Text] [Related]

  • 8. The role of calcium ions in factor X activation by thrombin E192Q.
    Le Bonniec BF, Guinto ER, Esmon CT.
    J Biol Chem; 1992 Apr 05; 267(10):6970-6. PubMed ID: 1551906
    [Abstract] [Full Text] [Related]

  • 9. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
    Smirnov MD, Safa O, Regan L, Mather T, Stearns-Kurosawa DJ, Kurosawa S, Rezaie AR, Esmon NL, Esmon CT.
    J Biol Chem; 1998 Apr 10; 273(15):9031-40. PubMed ID: 9535891
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO, Kalafatis M, Mann KG.
    Protein Sci; 1997 Sep 10; 6(9):2016-27. PubMed ID: 9300501
    [Abstract] [Full Text] [Related]

  • 12. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
    Shen L, Dahlbäck B, Villoutreix BO.
    Biochemistry; 2000 Mar 21; 39(11):2853-60. PubMed ID: 10715104
    [Abstract] [Full Text] [Related]

  • 13. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives.
    Rezaie AR, Esmon CT.
    J Biol Chem; 1992 Dec 25; 267(36):26104-9. PubMed ID: 1334492
    [Abstract] [Full Text] [Related]

  • 14. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF, Kalafatis M, Shatos M, Mann KG.
    Arterioscler Thromb Vasc Biol; 1997 Nov 25; 17(11):2765-75. PubMed ID: 9409254
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
    Hertzberg MS, Ben-Tal O, Furie B, Furie BC.
    J Biol Chem; 1992 Jul 25; 267(21):14759-66. PubMed ID: 1634519
    [Abstract] [Full Text] [Related]

  • 17. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
    Gale AJ, Sun X, Heeb MJ, Griffin JH.
    Protein Sci; 1997 Jan 25; 6(1):132-40. PubMed ID: 9007985
    [Abstract] [Full Text] [Related]

  • 18. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
    van der Neut Kolfschoten M, Dirven RJ, Vos HL, Tans G, Rosing J, Bertina RM.
    J Biol Chem; 2004 Feb 20; 279(8):6567-75. PubMed ID: 14660667
    [Abstract] [Full Text] [Related]

  • 19. Insight into the molecular basis of coagulation proteinase specificity by mutagenesis of the serpin antithrombin.
    Rezaie AR.
    Biochemistry; 2002 Oct 08; 41(40):12179-85. PubMed ID: 12356319
    [Abstract] [Full Text] [Related]

  • 20. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
    Mesters RM, Heeb MJ, Griffin JH.
    Protein Sci; 1993 Sep 08; 2(9):1482-9. PubMed ID: 8401232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.